NCT00774800View on ClinicalTrials.gov

Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Humalog

DRUG

Humulin-R

DRUG

Recombinant human hyaluronidase PH20 (rHuPH20)

OTHER

Liquid meal

Trial Locations (1)

91911

Profil Institute for Clinical Research, Inc., Chula Vista

Sponsors
All Listed Sponsors
lead

Halozyme Therapeutics

INDUSTRY

NCT00774800 - Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter